Shopping Cart 0
Cart Subtotal
USD 0

Sound Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Summary

Sound Pharmaceuticals Inc (SPI) is a biopharmaceutical company that develops therapeutics for sensorineural otologic diseases. The company's product pipeline includes SPI-1005, SPI-3005 and SPI-5557. Its SPI-1005 is a proprietary oral formulation of ebselen, a small molecule mimic and inducer of glutathione peroxidase used for treating acute noise-induced hearing loss (NIHL) and meniere's disease; SPI-3005 is a chemoprotection for tinnitus; and SPI-5557 is used for regeneration of deaf. SPI develops drugs to regenerate cells within the cochlea and restore hearing, for individuals with severe to profound hearing loss. The company conducts clinical trials for the development of preclinical models of hearing loss and tinnitus. SPI is headquartered in Seattle, Washington, the US.

Sound Pharmaceuticals Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Sound Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sound Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Sound Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sound Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Sound Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

Sound Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Sound Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Sound Pharma Raises USD8.4 Million in Series C-2 Venture Financing 11

Sound Pharma Raises Additional USD3.8 Million in Venture Financing 12

Sound Pharmaceuticals Raises USD0.03 Million in Venture Financing 13

Sound Pharma Raises USD 7.6 Million In Venture Financing 14

Partnerships 15

Sound Pharma to Partner with University of Oxford 15

Sound Pharmaceuticals Inc-Key Competitors 16

Sound Pharmaceuticals Inc-Key Employees 17

Sound Pharmaceuticals Inc-Locations And Subsidiaries 18

Head Office 18

Recent Developments 19

Product News 19

09/25/2017: Sound Pharmaceuticals initiates STOP Ototoxicity Study in Cystic Fibrosis 19

03/20/2017: Sound Pharmaceuticals announces USD 1.6 Million Award from Cystic Fibrosis Foundation Therapeutics to prevent and treat the hearing loss and tinnitus associated with antibiotic use 20

Clinical Trials 21

Nov 01, 2017: University of Oxford and Sound Pharmaceuticals begin Phase 2 clinical trial on novel treatment for bipolar disorder 21

Oct 03, 2017: Sound Pharmaceuticals announces positive Phase 1b results and the start of a Phase 2b clinical trial in Menieres Disease 22

Sep 29, 2017: Enrollment Underway in CF Clinical Trial for Ear Toxicity Caused by Antibiotics 23

Jun 27, 2017: Sound Pharmaceuticals completes enrollment on Meniere's Disease clinical trial 24

Appendix 25

Methodology 25

About GlobalData 25

Contact Us 25

Disclaimer 25


List Of Figure

List of Figures

Sound Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Sound Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Sound Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Sound Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Sound Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sound Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Sound Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sound Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Sound Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Sound Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2

Sound Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sound Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Sound Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sound Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Sound Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

Sound Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Sound Pharma Raises USD8.4 Million in Series C-2 Venture Financing 11

Sound Pharma Raises Additional USD3.8 Million in Venture Financing 12

Sound Pharmaceuticals Raises USD0.03 Million in Venture Financing 13

Sound Pharma Raises USD 7.6 Million In Venture Financing 14

Sound Pharma to Partner with University of Oxford 15

Sound Pharmaceuticals Inc, Key Competitors 16

Sound Pharmaceuticals Inc, Key Employees 17

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com